Marc Jozef Lauwereys

This inventor holds 16 USPTO granted patents and 14 published patent applications, plus 5 CIPO patents and 8 EPO patents. Top assignees: Ablynx N.v., Corvas International, Inc., Gist-Brocades N.v.. Active years: 1994-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marc Jozef Lauwereys. Retrieved from https://idiyas.com/inventor/marc-jozef-lauwereys

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 14)

% Patents Active = 100.0

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 13)

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 52(Granted Patents)

Company Filing History:

Corvas International, Inc.

Plant Genetic Systems N.v.

patents

where one patent can have more than one assignee

Years Active: 1994-2025

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12492239 - NOVEL ANTIGEN BINDING DIMER-COMPLEXES, METHODS OF MAKING/AVOIDING AND USES THEREOF (2025-12-09),

2. 12116607 - Method for the production of domain antibodies (2024-10-15),

3. 10919954 - Antigen binding dimer-complexes, methods of making/avoiding and uses thereof (2021-02-16),

4. 10005830 - Antigen binding dimer-complexes, methods of making/avoiding and uses thereof (2018-06-26),

5. 9884117 - Stable formulations of polypeptides and uses thereof (2018-02-06),

6. 9464138 - Method for the production of domain antibodies (2016-10-11),

7. 9371381 - Single domain antibodies directed against tumor necrosis factor-alpha and uses therefor (2016-06-21),

8. 9265834 - Stable formulations of polypeptides and uses thereof (2016-02-23),

9. 5945275 - Nematode-extracted anticoagulant protein (1999-08-31),

10. 5872098 - Nematode-extracted anticoagulant protein (1999-02-16),

11. 5866543 - Nematode-extracted anticoagulant protein (1999-02-02),

12. 5866542 - Nematode-extracted anticoagulant protein (1999-02-02),

13. 5864009 - Nematode-extracted anticoagulant protein (1999-01-26),

14. 5863894 - Nematode-extracted anticoagulant protein (1999-01-26),

15. 5585259 - Ecotin as a factor Xa, XIa, and XIIa inhibitor (1996-12-17),

Title: **Innovative Contributions of Marc Jozef Lauwereys**

Introduction

Marc Jozef Lauwereys, an accomplished inventor based in Haaltert, Belgium, has made significant strides in the field of biotechnology. With a portfolio of 14 patents to his name, Lauwereys has contributed innovative methods and processes that enhance the production and efficacy of antibodies, which are crucial in various therapeutic applications.

Latest Patents

Among his latest inventions is a patented method for the production of domain antibodies. This process involves using yeast to promote the formation of disulfide bridges in the domain antibodies. The addition of oxidizing agents, particularly oxidizing metal ions like Cu2+, Fe2+, Fe3+, and Zn2+, plays a key role in this method. Lauwereys' other notable patent focuses on antigen binding dimer-complexes. It describes novel dimer-complexes known as non-fused dimers (NFDs), which consist of either homodimers or heterodimers of single variable domains. These NFDs exhibit improved binding characteristics compared to their monomeric counterparts and can be engineered for enhanced stability. The patent also outlines specific conditions for forming these complexes and how to avoid their formation when necessary.

Career Highlights

Throughout his career, Marc Jozef Lauwereys has been associated with several esteemed companies in the biotechnology sector, including Corvas International, Inc. and Ablynx N.V. His professional journey reflects a deep commitment to advancing scientific knowledge and developing groundbreaking innovations in antibody technology.

Collaborations

Lauwereys has collaborated with notable professionals in the industry, including George Phillip Vlasuk and Patrick Eric Stanssens. These partnerships have contributed to furthering research and development projects aimed at enhancing antibody production techniques and therapeutic applications, demonstrating the power of collaboration in scientific advancements.

Conclusion

The innovative work of Marc Jozef Lauwereys exemplifies the critical role of inventors in the evolution of biotechnology. His multiple patents not only underscore his expertise but also signify important advancements in the production of antibodies that can lead to improved therapies. As he continues to push the boundaries of science, Lauwereys remains a prominent figure in the field of biotechnology innovation.

Profile summary based on public USPTO records.